COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …
A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2
JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
AA Zasada, A Darlińska, A Wiatrzyk, K Woźnica… - Viruses, 2023 - mdpi.com
The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …
It became clear that the development of an effective vaccine was the only way to stop the …
[HTML][HTML] SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …
The COVID-19 vaccines: recent development, challenges and prospects
Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus
R Mukherjee - Journal of biosciences, 2020 - Springer
COVID-19 is an emerging infectious disease that has turned into a pandemic. It spreads
through droplet transmission of the new coronavirus SARS-CoV-2. It is an RNA virus …
through droplet transmission of the new coronavirus SARS-CoV-2. It is an RNA virus …
SARS-CoV-2 vaccine development: an overview and perspectives
Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
[HTML][HTML] The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution
RM Burgos, ME Badowski, E Drwiega… - Drugs in …, 2021 - ncbi.nlm.nih.gov
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …